Readers hoping to buy Cohen & Steers, Inc. ( NYSE:CNS ) for its dividend will need to make their move shortly, as the... Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under ...
Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel Goldlust Access the segment here HOUSTON, TX / ACCESSWIRE / October 10 ...
Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European ...
If we miss even one of these pillars, we will not be able to achieve TB elimination," added Dr Burhan. And we have to find, treat and prevent TB in a people-centred, rights-based and gender ...
New therapies will allow patients greater choice and flexibility in the control of CNS disorders BARCELONA , Spain, DÜSSELDORF, Germany , and ATHENS, Greece , Dec.